Treatment of Chronic Active Antibody-mediated Rejection With Pulse Steroids, IVIG, With or Without Rituximab is Associated With Increased Risk of Pneumonia

by Emily Joachim, MD, Sandesh Parajuli, MBBS, Kurtis J. Swanson, MD, Fahad Aziz, MBBS, Neetika Garg, MBBS, Maha Mohamed, MD, Didier Mandelbrot, MD, Arjang Djamali, MD
Published 2021-01-01